Ep 236: 3 Updated Guidelines for Neuromuscular Blocking Agents

Check out the timestamps below to help you navigate through the many topics we discussed.

On This Episode:

Even in 2023, residual paralysis from neuromuscular blocking agents (NMBA) is still a problem. Recently a task force developed by the ASA released guidelines for the reversal of NMBA. Jeremy and Sass examine these guidelines and talk about what they mean for current anesthesia practice.

Here are some of the things you’ll learn on this show:

• Background on this report and the three primary reasons for these guidelines. [2:30]
• What to know about the Train of Four ratio [6:34]
• The first three recommendations the guidelines provide. [10:31]
• Recommendations four through seven. [17:33]
• The final recommendation about atracurium and cisatracurium. [26:23]

Check out the interview at the top of the page and use the timestamps to help you navigate through the many topics we discussed.